REQUEST A DEMO
Total
USD $0.00
Search more companies

Tg Pharma Sp. z o.o. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Secondary Activities: Pharmaceutical Preparation Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Department Stores
Full name: Tg Pharma Sp. z o.o. Profile Updated: August 10, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Tg Pharma Sp. z o.o. is a company in Poland, with a head office in Warsaw. The company operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. The company was established on September 02, 2020. A growth of 76.64% was recorded in its total assets.

Headquarters
Ul. Sienna 86/100
Warsaw; Mazowieckie; Postal Code: 00-815

Contact Details: Purchase the Tg Pharma Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Tg Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Tg Pharma Sp. z o.o. report to view the information.
Incorporation Date:
September 02, 2020
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
W Organie Czlonek Zarzadu Reprezentujacym
Ownership Details
Purchase this report to view the information.
31%
Purchase this report to view the information.
31%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Tg Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total operating revenue
64.06%
Operating profit (EBIT)
20.34%
Net Profit (Loss) for the Period
20.14%
Total assets
76.64%
Total equity
89.42%
Return on Equity (ROE)
549.13%
Debt to Equity Ratio
-248.33%
Quick Ratio
0.58%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?